SCHEMBL24607798

SCHEMBL24607798

Cc1ccc2c(c1Br)n(C)c(=O)n2COCC[Si](C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.38
▸ DGAT1 O75907 1/20 0.35
▸ TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25337708 0.87 NPC1 (0.38) NPC1DGAT1TSHR
SCHEMBL24607484 0.86 NPC1 (0.37) NPC1DGAT1
SCHEMBL31129761 0.82 NPC1 (0.38) NPC1DGAT1TSHR
SCHEMBL31276144 0.82 NPC1 (0.40) NPC1DGAT1TSHR
SCHEMBL29502401 0.81 NPC1 (0.41) NPC1DGAT1TSHR
SCHEMBL13015496 0.81 NPC1 (0.41) NPC1DGAT1TSHR
SCHEMBL24668167 0.78 NPC1 (0.42) NPC1DGAT1TSHR
SCHEMBL29729427 0.78 NPC1 (0.42) NPC1DGAT1TSHR
SCHEMBL31276238 0.77 NPC1 (0.43) NPC1TSHR
SCHEMBL30702016 0.77 NPC1 (0.34) NPC1DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4271664-A1 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2023-11-08 — — EP disclosed
CN-116867758-A IRAK degradation agents and uses thereof 凯麦拉医疗公司 2023-10-10 — — CN disclosed
WO-2022147465-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-07-07 — — WO disclosed
WO-2022147465-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-07-07 — — WO disclosed
Send feedback